Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase III Randomized, Double-blind, Placebo-controlled, 2-period Crossover, Multicenter Study to Assess the Effect of Indacaterol (300 µg o.d.) on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
indacaterol
CQAB149B2311
NCT00620022
Chronic Obstructive Pulmonary Disease (COPD)
Phase 3
 
June 2016

Powered by ideaPoint, Inc.